Exercise program using an app for individuals with post-COVID-19 syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of a mobile app-based exercise program on the physical and cardiovascular function of individuals suffering from post-COVID-19 syndrome. A total of 60 participants will be randomly assigned to either a control group that follows standard physical activity guidelines or an experimental group that engages in app-based training. The primary focus is to assess improvements in functional parameters related to fatigue and dyspnea. The study aims to provide a structured approach to rehabilitation for those affected by lingering symptoms of COVID-19.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Laboratory diagnosis of COVID-19
* Fatigue ≥ 8 points on the Chalder Scale and/or dyspnea 2-4 on the Modified Medical Research Council
* Have access to a smartphone
* Have no contraindications for exercise practice
* Have ability to sit and stand and maintain balance while standing
* Have preserved cognitive function
* Have no risk of falls according to the Morse Fall Scale

Where it's running

• Universidade Nove de Julho
  São Paulo, São Paulo, Brazil Recruiting

Study contacts

• Principal investigator: Fernanda Corrêa, PhD — University of Nove de Julho
• Study coordinator: Raphael Ritti-Dias, PhD
• Email: raphaelritti@gmail.com
• Phone: +55 19 99940 6878

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Second cohort following patients entering a multidisciplinary care pathway for post-COVID syndromes (SyPoCo2)

  This project will test whether linking long COVID patients' symptoms with blood immune and molecular markers can find biomarkers and possible treatment targets.

  Recruiting at 2 sites Hospices Civils de Lyon · Pierre-Bénite and 1 other locations · NCT07356570

• Accelerated intermittent theta-burst stimulation for depression with post‑COVID‑19 condition

  This will test whether two different schedules of intermittent theta-burst stimulation (accelerated TMS) reduce depressive symptoms and inflammation in adults aged 18–65 who have depressive disorder plus post‑COVID‑19 condition.

  Recruiting Max-Planck-Institute of Psychiatry · Munich, Bavaria · NCT07197138

• 2-HOBA to reduce persistent immune activation in Long COVID with POTS

  This trial will test whether 2‑HOBA, a compound that scavenges harmful IsoLG-adducts, can reduce immune activation in adults with Long COVID who have POTS.

  Recruiting Phase 2 Vanderbilt University Medical Center · Nashville, Tennessee · NCT07189936

• Long COVID relief through learning mindfulness

  This study will try an 8-week online recorded mindfulness program to see if it reduces stress and Long COVID symptoms in adults who continue their usual care.

  Recruiting Columbia University · New York, New York · NCT07140094

• Investigating dysfunctional breathing in patients with post COVID-19 condition

  This study is trying to see how breathing problems affect people who are dealing with long-term symptoms after having COVID-19.

  Recruiting Karolinska Institutet · Stockholm, Solna and 1 other locations · NCT06776263

• Evaluating Apabetalone for Long-COVID in Diabetes Patients

  This study is testing if adding a new medication called Apabetalone to the diabetes drug dapagliflozin can help people with Type 2 Diabetes who are dealing with Long-COVID symptoms feel better.

  Recruiting Phase 2/3 Resverlogix Corp · Amman and 2 other locations · NCT06590324

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.